Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag for Thrombocytopenia in Chronic HCV (ENABLE 1)
NCT00529568Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2007
- Primary completion
- Aug 2011
- Countries
- 23
01
Overview
A Phase 3 trial of eltrombopag in Thrombocytopenia, sponsored by GSK. Started Oct 2007; status: completed.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00529568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529568.